Substance Use Guides, Research, Toolkits, & More

SAMHSA Mobile App to Support Medication-Assisted Treatment of Opioid Use Disorder
The app, called MATx, features information on treatment approaches and medications, a buprenorphine prescribing guide, clinical support tools, and access to helplines.


Promoting Care for Pregnant/Parenting Women with Opioid Use Disorder and Their Infants
Two SAMHSA-issued reports on the best approaches for optimizing outcomes for pregnant and parenting women with opioid use disorders.
CDC Guideline for Prescribing Opioids for Chronic Pain
This guideline is for primary care clinicians to follow when treating adult patients for chronic pain in outpatient settings. Includes clinical tools, patient/partner fact sheets, graphics, and a decision-making checklist for clinicians.
FDA Opioids Action Plan Fact Sheet
Outlines the FDA's actions to address the opioid abuse, dependence, and overdose in the US.
VA/DoD Management of Substance Use Disorder Guidelines
The guideline provides clear and comprehensive evidence based recommendations incorporating current information and practices for practitioners throughout the DoD and VA Health Care systems.
Guide: Medication for the Treatment of Alcohol Use Disorder
SAMHSA pocket guide for health professionals that includes a checklist for prescribing medication, approved medications for use in the treatment of alcohol use disorder, and standard drink sizes/recommended limits.
Buprenorphine: A Guide for Nurses
SAMHSA guide on the use of buprenorphine to treat opioid addiction as well as suggestions for working with community providers to improve treatment outcomes.
Federal Guidelines for Opioid Treatment Programs
SAMHSA guidelines for the operation of opioid treatment programs, covering patient assessment, treatment planning, medication-assisted treatment (methadone and buprenorphine), overdose and relapse prevention, and recovery care.
Medicaid Benefits for the Treatment of Opioid Use Disorder
American Society of Addiction Medicine interactive map which lays out states' Medicaid fee-for-service benefit coverage for medications approved to treat opioid dependence.
Opioid Overdose Prevention Toolkit
Equips communities with material to develop policies and practices to prevent opioid-related overdoses and deaths. Addresses issues for first responders, treatment providers, and those recovering from opioid overdose.
Substance Abuse and Mental Health Data Archive
From SAMHSA, a site to download data, conduct online analyses, develop custom Quick Tables, and view Interactive Maps.
Treatment Episode Data Set - Admissions (TEDS-A)
Collected annually, provides details on individual treatment admissions throughout the United States.
National Survey of Substance Abuse Treatment Services
SAMHSA point-prevalence survey conducted annually. Provides data on substance abuse treatment facilities and their clients throughout the US.
ONDCP 2014 Strategy Fact Sheet
Outlines main elements of Obama Administration's 2014 National Drug Control Strategy, covering opioids, drug use prevention, early intervention, access to treatment, recovery, and law enforcement.
Challenges of Pregnant Teens in Substance Abuse Treatment
Pregnant teen substance abuse treatment admissions tend to involve greater challenges than other female teen admissions in a number of key areas, such as financial and educational status.
General Principles for Use of Pharmacological Agents to Treat Individuals with Co-Occurring Mental and Substance Use Disorders
General principles to assist in the planning, delivery, and evaluation of pharmacologic approaches to support the recovery of individuals with co-occurring disorders.
Substance Abuse and the Emergency Care Setting
Emergency Nurses Association's position statement regarding substance abuse in the emergency care setting.
Results from the 2013 National Survey on Drug Use and Health
Primarily measures the prevalence and correlates of drug use in the United States. Provides info on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older.
Pharmacologic Guidelines for Treating Individuals with PTSD & Co-Occurring Opioid Use Disorders
Guidelines for medication-assisted treatment for individuals with post-traumatic stress disorder (PTSD) and co-occurring opioid use disorders.
Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence
Overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.
The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision
Discusses the role of alcohol biomarkers in the clinical, medical, and forensic settings and examines strategies for their use and interpretation in circumstances such as clinical, criminal justice, and impaired healthcare provider settings.
Epidemic: Responding to America's Prescription Drug Abuse Crisis (pdf) 2011 document outlining ONDCP's national prescription drug abuse prevention plan. Addressing the Specific Behavioral Health Needs of Men
Reviews gender-specific research and best practices, such as common patterns of initiation of substance use among men and specific treatment issues and strategies. (pdf)
FAQs on 42 CFR Part 2
A set of answers to frequently asked questions (FAQs) on protecting the confidentiality of clients for substance abuse treatment providers.
Managing Chronic Pain in Adults With or in Recovery From SUDs
SAMHSA Treatment Improvement Protocol that provides clinicians with practical guidance and tools for treating chronic pain and SAMHSA's best-practice guidelines for prevention and treatment of substance use and mental disorders. (pdf)
Addressing the Specific Needs of Women
Reviews gender-specific research and best practices, such as common patterns of initiation of substance use among women and specific treatment issues and strategies. (pdf)
Co-Occurring Mental and Substance Abuse Disorders
This guide by the U.S. Department of Health and Human Services discusses some of the difficulties faced by dual diagnosis treatment programs. (pdf)

APNA is not responsible for the content of external websites.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.